APA (7th ed.) Citation

Kelly, R. J., Thomas, A., Rajan, A., Chun, G., Lopez-Chavez, A., Szabo, E., . . . Giaccone, G. (2013). A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer. Annals of Oncology, 24(10), 2601. https://doi.org/10.1093/annonc/mdt249

Chicago Style (17th ed.) Citation

Kelly, R. J., et al. "A Phase I/II Study of Sepantronium Bromide (YM155, Survivin Suppressor) with Paclitaxel and Carboplatin in Patients with Advanced Non-small-cell Lung Cancer." Annals of Oncology 24, no. 10 (2013): 2601. https://doi.org/10.1093/annonc/mdt249.

MLA (9th ed.) Citation

Kelly, R. J., et al. "A Phase I/II Study of Sepantronium Bromide (YM155, Survivin Suppressor) with Paclitaxel and Carboplatin in Patients with Advanced Non-small-cell Lung Cancer." Annals of Oncology, vol. 24, no. 10, 2013, p. 2601, https://doi.org/10.1093/annonc/mdt249.